PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
December 6, 2022Expert Review of Anti-infective Therapy24 citations

Escalation of antimicrobial resistance among MRSA part 1: focus on global spread

View Full Paper
JLJoseph P. LynchGZGeorge G. Zhanel

Key Points

Key points are not available for this paper at this time.

Abstract

INTRODUCTION: isolates exhibit considerable diversity though specific genotypes have been associated with antimicrobial resistance (AMR) and toxin gene profiles. MRSA is an important pathogen causing both community-acquired (CA) and healthcare-acquired (HCA) infections. Importantly, over the past several decades, both HCA-MRSA and CA-MRSA have spread all over the globe. Even more concerning is that CA-MRSA clones have disseminated into hospitals and HCA-MRSA have entered the community. Factors that enhance spread of MRSA include: poor antimicrobial stewardship and inadequate infection control. The emergence and spread of multidrug resistant (MDR) MRSA has limited therapeutic options. AREAS COVERED: . EXPERT OPINION: Over the past several decades, MRSA has spread all over the globe. We encourage the judicious use of antimicrobials in accordance with antimicrobial stewardship programs along with infection control measures to minimize the spread of MRSA.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Lynch et al. (2022) studied this question.

synapsesocial.com/papers/6a038fd32f5c7ec1156b3f11https://doi.org/10.1080/14787210.2023.2154653
Ask AI
Helpful
Bookmark
Share
View Full Paper